Skip to main content
Novartis AG (NVS)
NYSE: NVS · Real-Time Price · USD
145.50
+1.31 (0.91%)
At close: Apr 28, 2026, 4:00 PM EDT
145.92
+0.42 (0.29%)
After-hours: Apr 28, 2026, 7:55 PM EDT

Novartis AG Revenue

Novartis AG had revenue of $13.52B in the quarter ending March 31, 2026, a decrease of -0.70%. This brings the company's revenue in the last twelve months to $56.58B, up 6.31% year-over-year. In the year 2025, Novartis AG had annual revenue of $56.67B with 9.57% growth.

Revenue (ttm)
$56.58B
Revenue Growth
+6.31%
P/S Ratio
4.90
Revenue / Employee
$751,697
Employees
75,267
Market Cap
277.36B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202556.67B4.95B9.57%
Dec 31, 202451.72B5.06B10.85%
Dec 31, 202346.66B3.20B7.36%
Dec 31, 202243.46B-513.00M-1.17%
Dec 31, 202143.97B-5.92B-11.87%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Johnson & Johnson 96.36B
Merck & Co. 65.01B
Pfizer 62.58B
AbbVie 61.16B
AstraZeneca 58.74B
Sanofi 54.85B
Novo Nordisk 48.59B
Bristol-Myers Squibb Company 48.19B
Revenue Rankings

NVS News

More News